Strategic partnership Theragenics recently signed a large-scale copper-64 manufacturing supply agreement with Clarity Pharmaceuticals, signaling openness to new radiopharmaceutical collaborations and potential cross-selling opportunities with other radiopharmacy players.

Prostate care focus Active participation in multiple prostate cancer events and hands-on brachytherapy workshops indicates a strong market emphasis on prostate brachytherapy, suggesting opportunities for accessories, training, and case support services aligned with this niche.

Education and patient support Launch of Life After Seeds resources and expanded patient education materials create demand for companion patient information platforms, clinical support tools, and patient engagement services that can be offered or co-branded.

Radiopharmaceutical capabilities As a veteran radioisotope producer with a focus on radiopharmaceuticals and LDR brachytherapy, Theragenics may benefit from complementary suppliers, equipment, and software partners (ERP, CRM, analytics) to optimize production, scheduling, and regulatory compliance.

Growth and visibility Active participation in major conferences (EANM, ABS workshops) and a mid-size revenue profile position Theragenics as a scalable partner for distributors, OEMs, or service providers targeting radiopharmacy clinics and cancer treatment centers.